Targeting prEssure-Muscle-index to Avoid Ventilatory Over-Assistance During Pressure Support Ventilation
TEMA
1 other identifier
interventional
36
1 country
1
Brief Summary
The TEMA study (Targeting prEssure-Muscle-index to avoid ventilatory over-Assistance during pressure support ventilation) is a prospective, interventional crossover trial investigating the relationship between pressure support (PS) and tidal volume (Vt) in ICU patients with acute hypoxemic respiratory failure (AHRF) receiving pressure support ventilation (PSV). The study aims to assess whether the Pressure-Muscle Index (PMI)-a marker derived from the difference between plateau and peak inspiratory pressure-can help identify the optimal level of ventilatory assistance, preventing over-assistance and its associated complications such as diaphragm atrophy and patient self-inflicted lung injury (P-SILI). By exploring the sigmoidal relationship between PS and Vt, the study seeks to define a physiological threshold (PMI=0) that may serve as a personalized target for PSV titration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2025
CompletedFirst Posted
Study publicly available on registry
April 10, 2025
CompletedStudy Start
First participant enrolled
October 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 8, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 8, 2027
February 3, 2026
January 1, 2026
1.5 years
March 11, 2025
January 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pressure Support-Tidal Volume (PS-Vt) Relationship
The primary aim is to determine whether the PS-Vt curve exhibits a flat region (where tidal volume remains stable) before transitioning into a steep, compliance-dependent increase at higher PS levels. This transition point, identified as PSPMI=0, is hypothesized to represent the threshold for over-assistance.
Up to 5 minutes after each PS level adjustment during the interventional phase (Day 1)
Secondary Outcomes (11)
Validation of Pressure-Muscle Index (PMI) as an Over-Assistance Marker
Up to 5 minutes after each PS level adjustment during the interventional phase (Day 1) and during follow-up assessment on Days 4-6 (if patient remains intubated)
Impact of Respiratory Mechanics on PS-Vt Relationship
During the interventional phase on Day 1 and during follow-up assessment on Days 4-6 (if patient remains intubated)
Rate of Ineffective Efforts During Over-Assistance
Up to 5 minutes after each PS level adjustment during the interventional phase (Day 1) and during follow-up assessment on Days 4-6 (if patient remains intubated)
Effect of Over-Assistance on Ventilatory Asynchronies
Up to 5 minutes after each PS level adjustment during the interventional phase (Day 1) and during follow-up assessment on Days 4-6 (if patient remains intubated)
Weaning failure
Up to 100 months or until the of death from any cause, whichever came first.
- +6 more secondary outcomes
Study Arms (7)
Pressure Support PMI=0
EXPERIMENTALThe PS level at which PMI is zeroed, meaning the patient's inspiratory effort contributes minimally to tidal volume
Pressure Support +2
EXPERIMENTALAbove PSPMI=0: +2 cmH₂O above PSPMI=0 (over-assistance zone).
Pressure Support +4
EXPERIMENTALAbove PSPMI=0: +4 cmH₂O above PSPMI=0 (over-assistance zone).
Pressure Support +6
EXPERIMENTALAbove PSPMI=0: +6 cmH₂O above PSPMI=0 (over-assistance zone).
Pressure Support -2
EXPERIMENTALBelow PSPMI=0: -2 cmH₂O below PSPMI=0 (under-assistance zone).
Pressure Support -4
EXPERIMENTAL\- Below PSPMI=0: -4 cmH₂O below PSPMI=0 (under-assistance zone).
Pressure Support -6
EXPERIMENTAL\- Below PSPMI=0: -6 cmH₂O below PSPMI=0 (under-assistance zone).
Interventions
Patients will undergo six randomized PS levels (+2, +4, +6 cmH₂O above and -2, -4, -6 cmH₂O below PSPMI=0).
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Mechanically ventilated in the ICU
- Diagnosis of Acute Hypoxemic Respiratory Failure (AHRF)
- Normocapnia or non-severe hypercapnia
- Receiving Pressure Support Ventilation (PSV) for at least 24-72 hours
- Presence of an arterial line for blood gas sampling
You may not qualify if:
- Age \< 18 years
- Known neurological or neuromuscular disorders affecting diaphragm function
- Chronic Obstructive Pulmonary Disease (COPD) or hypercapnic respiratory failure
- Psychomotor agitation or inadequate sedation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Santa Chiara Hospital, Trento, Trentino-Alto Adige, Italy
Trento, Trento, 38122, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor Giacomo Bellani
Study Record Dates
First Submitted
March 11, 2025
First Posted
April 10, 2025
Study Start
October 8, 2025
Primary Completion (Estimated)
April 8, 2027
Study Completion (Estimated)
April 8, 2027
Last Updated
February 3, 2026
Record last verified: 2026-01